Treatment of DKD with mesenchymal stem cell therapy significantly decreased fibrosis indicators, including fibronectin, and improved renal function (blood urea nitrogen and serum creatinine) and urinary albumin [43]. The gene discussed is FN1; the disease is diabetic kidney disease.